Clinical Trial Update: Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia [Phase 3]

View source ↗

Summary

Phase 3 trial of a tetravalent dengue vaccine in healthy adults completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Tetravalent dengue vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Status: COMPLETED | Results posted: 2019-07-24